Predictive models for HERG channel blockers: ligand-based and structure-based approaches.

Area of Science:

• Pharmacology
• Computational Chemistry
• Drug Discovery

Background:

• Acquired long QT syndrome, a severe side effect of drug candidates blocking the hERG K+ channel, poses significant risks in clinical trials.
• Early prediction of hERG K+ channel affinity is essential for mitigating drug-induced cardiotoxicity and improving drug development success rates.

Purpose of the Study:

• To review in silico approaches for predicting drug interactions with the hERG channel.
• To highlight the importance of in vitro biological testing systems and consensus strategies for enhancing predictive accuracy.

Main Methods:

• Review of structure-based and ligand-based computational methods for hERG channel interaction prediction.
• Discussion of in vitro assays relevant to hERG channel function.
• Exploration of consensus modeling approaches to improve predictive performance.

Main Results:

• In silico methods offer valuable tools for early assessment of hERG channel affinity.
• Integration of computational predictions with in vitro data enhances the reliability of safety assessments.
• Consensus approaches can improve the overall accuracy of hERG liability prediction.

Conclusions:

• Accurate prediction of hERG channel affinity is vital for safe drug discovery.
• A combination of in silico, in vitro, and consensus strategies provides a robust framework for evaluating drug candidates.
• Continued development of predictive models will accelerate the identification of safer therapeutics.